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ABSTRACT 
Objective: Neuropeptide Y and its Y receptors are important players in the regulation of 
energy homeostasis. However, while their functions in feeding regulation are well recognized, 
functions in other critical aspects of energy homeostasis are largely unknown. To investigate 
the function of Y1 receptors in the regulation of energy homeostasis, we examined energy 
expenditure, physical activity, body composition, oxidative fuel selection and mitochondrial 
oxidative capacity in germline Y1−/− mice as well as in a conditional Y1-receptor-knockdown 
model in which Y1 receptors were knocked down in peripheral tissues of adult mice. 
Results: Germline Y1−/− mice of both genders not only exhibit a decreased respiratory 
exchange ratio, indicative of increased lipid oxidation, but interestingly also develop late-onset 
obesity. However, the increased lipid oxidation is a primary effect of Y1 deletion rather than 
secondary to increased adiposity, as young Y1−/− mice are lean and show the same effect. The 
mechanism behind this is likely because of increased liver and muscle protein levels of 
carnitine palmitoyltransferase-1 (CPT-1) and maximal activity of key enzymes involved in β-
oxidation; β-hydroxyacyl CoA dehydrogenase (βHAD) and medium-chain acyl-CoA 
dehydrogenase (MCAD), leading to increased mitochondrial capacity for fatty acid transport 
and oxidation. These effects are controlled by peripheral Y1-receptor signalling, as adult-onset 
conditional Y1 knockdown in peripheral tissues also leads to increased lipid oxidation, liver 
CPT-1 levels and βHAD activity. Importantly, these mice are resistant to diet-induced obesity. 
Conclusions: This work shows the primary function of peripheral Y1 receptors in the 
regulation of oxidative fuel selection and adiposity, opening up new avenues for anti-obesity 
treatments by targeting energy utilization in peripheral tissues rather than suppressing 
appetite by central effects. 
 
INTRODUCTION 
Obesity, an epidemic disorder and the leading risk factor for type 2 diabetes, develops through 
a prolonged imbalance between energy intake and energy expenditure. Neuropeptide Y (NPY), 
a 36-amino-acid peptide, is a key regulator of energy metabolism. Increased central NPY-ergic 
tone elicits robust hyperphagia and induces a series of obesogenic changes that lead to gain of 
body weight and fat.bib11, bib22, bib33, bib44, bib55, bib66 These obesefying changes include decreases 
in body temperature and thermogenetic capacity in brown adipose tissuebib55, bib77, bib88, bib99, 
bib1010—indicative of decreased energy expenditure, glucose partitioning towards storage rather 
than utilization,bib22, bib1111 increased lipogenic activity in white adipose tissue and liver,bib77, 
bib88, bib1212 and increased respiratory exchange ratio (RER)bib1313, bib1414, bib1515—indicative of a 
higher preference for carbohydrate versus lipid as a fuel source. Importantly, when NPY-
induced hyperphagia is prevented by pair feeding, central administration of NPY for 5–7 days 
in rodents still leads to significant fat gain without changes in body weight,bib22, bib1212 showing 
an important function of NPY in increasing adiposity independent of changes in food intake and 
body weight. 
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 NPY exerts its effects through activation of at least five G-protein-coupled receptors: 
Y1, Y2, Y4, Y5 and y6.bib1616 The Y1 receptor has received particular attention because of its 
status as a potential ‘feeding receptor’.bib1515, bib1717, bib1818, bib1919, bib2020, bib2121 Recent 
pharmacological studies suggest that Y1 receptors are not only involved in NPY-mediated 
feeding, but also in the control of energy metabolism.bib1515 Thus, agonism of Y1 receptors 
increases RER, indicative of lower lipid oxidation, without significant effects on energy 
expenditure.bib1515 However, as Y-receptor ligands are renowned for their lack of bioavailability 
and specificity, effects of antagonizing Y1 receptors on energy metabolism in vivo are difficult 
to examine pharmacologically. Therefore, we performed a systematic investigation of energy 
expenditure and substrate oxidation, combined with measurements of physical activity and 
body composition, in mouse models with Y1-receptor deficiency. As germline Y1-receptor-
knockout mice develop late-onset obesity,bib2222, bib2323, bib2424, bib2525 and as weight gain in itself 
is known to have significant effects on energy metabolism,bib2626 we also studied groups of 
younger germline Y1-knockout mice to enable definitive investigation of the primary effects of 
Y1-receptor deficiency on energy metabolism. 
 It is important to note that both NPY and Y1 receptors are expressed in peripheral 
tissues as well as in the brain.bib2727, bib2828, bib2929, bib3030 Peripheral Y1-receptor signalling could, 
therefore, conceivably be involved in the regulation of energy balance, as is the case for 
peripheral Y2 receptors.bib3131 Although pharmacological studies with central administration of 
NPY and/or Y1 ligands have established a function of central Y1 receptors in mediating NPY's 
effects on food intake,bib1515, bib3232, bib3333 little is known about the function of peripherally 
expressed Y1 receptors in the regulation of energy homeostasis. Moreover, NPY and the Y-
receptor system are known for their complexity and plasticity, as evidenced by compensatory 
changes in the expression of Y receptors when the ligandbib3434 or Y-receptor subtype(s)bib3535, 
bib3636 are completely ablated. Such compensatory changes in the NPY-ergic system in 
response to complete germline knockout of one of its components may at least contribute to 
some discrepant findings that have been reported between germline knockout studies and 
pharmacological studies.bib1515, bib2525, bib3737 Therefore, to study the function of peripheral Y1 
receptors in the regulation of energy homeostasis while reducing the impact of possible 
compensatory responses to gene deletion, we generated a conditional Y1-receptor-knockdown 
mouse model in which Y1 receptor was partially deleted specifically in peripheral tissues of 
adult mice. Understanding the functions of central versus peripheral Y1 receptors in the 
regulation of energy homeostasis is of critical importance for the development of novel anti-
obesity pharmaceuticals based on Y-receptor antagonism. For instance, rather than interfering 
with Y1-receptor-mediated appetite control in the brain, with its potential side effects on 
behaviour and emotionality, targeting peripheral Y1-receptor-mediated control of energy 
utilization could be an attractive alternative. 
 
MATERIALS AND METHODS 
 
Animals 
All research and animal care procedures were approved by the Garvan Institute/St Vincent's 
Hospital Animal Ethics Committee and were in agreement with the Australian Code of Practice 
for the Care and Use of Animals for Scientific Purpose. Mice were housed under conditions of 
controlled temperature (22 °C) and illumination (12-h light cycle, lights on at 07:00). All mice 
were fed a normal chow diet ad libitum (8% calories from fat, 21% calories from protein, 71% 
calories from carbohydrate and 2.6 kcal g–1; Gordon's Speciality Stock Feeds, Yanderra, NSW, 
Australia). Details of generation of the germline Y1-receptor-knockout mice were published 
earlier.bib3838 Y1-conditional-knockdown mice were generated by crossing mice harbouring the 
Y1-receptor gene flanked by recombinase recognition (LoxP) sites (Y1lox/lox) onto transgenic 
mice expressing Cre-recombinase under the control of interferon-responsive Mx1 promoter. 
This Mx1-activated Cre-mediated gene deletion has been shown to be partial and to 
preferentially target tissues in the periphery, with almost no effect on gene expression in the 
brain.bib3939 In our model, deletion of the Y1-receptor gene was induced in mice at 13 weeks of 
age through i.p. injection of synthetic double-stranded RNA (polyinosinic–polycytidylic acid; 
Poly I:C 300 µg per injection; Sigma-Aldrich Inc., St Louis, MO, USA) three times at 2-day 
intervals as described earlier.bib3939 Commencement of induction was defined as the day of the 
first Poly I:C injection. At 5 weeks after commencement of induction, various tissues and  
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organs (the hypothalamic region of the brain, liver, heart and skeletal muscle, pancreas, 
retroperitoneal white adipose tissue and brown adipose tissue) from control mice and 
conditional Y1-knockdown mice were collected and genomic DNA was isolated. Mx1-Cre-
induced Y1-receptor gene deletion in these tissues and organs were assessed by PCR using 
primer sets A and B that give PCR products in the absence or presence of the Y1 gene, as 
described earlier.bib3838 
 Indirect calorimetry studies were carried out on male and female Y1−/− and wild-type 
mice at 9 and 15 weeks of age. Female Y1-receptor conditional knockdown mice were studied 
by indirect calorimetry at 3 and 5 weeks after commencement of induction of gene deletion. 
Data obtained at these two time points were comparable, thus data at 5 weeks after the 
commencement of induction of gene deletion were presented. Food intake and rectal 
temperature were measured in conditional Y1-receptor-knockdown mice at 4 weeks after the 
commencement of induction of gene deletion. Rectal temperature was measured at ~09.00 h 
with a thermometer connected to a rectal probe (BAT-10 multipurpose thermometer; 
Physitemp Instruments, Clifton, NJ, USA). Temperature readings were taken within 10 s of 
removing the mouse from its cage. At the completion of each study, mice were culled between 
12.00 and 15.00 h by cervical dislocation followed by decapitation for collection of trunk 
blood. Serum was stored at −20 °C for subsequent analysis as described below. White 
adipose tissue depots (inguinal, epididymal retroperitoneal and mesenteric), brown adipose 
tissue, brain, pancreas, liver, heart and skeletal muscle were removed, weighed and frozen 
until further analysis by PCR genotyping, radio-ligand binding assay, western blotting and/or 
enzyme activity assays as described below. A separate set of female conditional Y1-receptor-
knockdown and control mice at 13 weeks of age were fed with a high fat diet (23% calories 
from fat, 19.4% calories from protein, 4.7% calories from crude fibre, 4.7% calories from acid 
detergent fibre and 20 MJ kg–1; Specialty Feeds, Glen Forrest, WA, Australia) for 21 weeks. 
Body composition through dual-energy X-ray absorptiometry, energy metabolism, food intake 
and rectal temperature were measured after 15 weeks of high fat feeding. On completion of 
the study, mice were culled for collection of trunk blood for determination of serum insulin 
levels, and white adipose tissue depots (inguinal, epididymal retroperitoneal and mesenteric) 
were dissected and weighed as described above. 
 
Food intake 
Food intake was measured in wild-type and Y1−/− mice at 9–10 weeks of age, chow-fed control 
and conditional Y1-receptor-knockdown mice at 4 weeks after the commencement of induction 
of gene deletion, as well as high fat diet-fed control and conditional Y1-receptor-knockdown 
mice after 15 weeks of high fat feeding. Mice were transferred from group housing on soft 
bedding to individual cages with paper towel bedding and allowed to acclimatize for 3 days. 
Food intake determined as the averages of triplicate readings were taken over 3 consecutive 
days. Actual food intake was calculated as the weight of pellets taken from the food hopper 
minus the weight of food spillage in the cage. Foetal weight was also determined in triplicate 
during these analyses. 
 
Indirect calorimetry 
Metabolic rate was measured by indirect calorimetry using an eight-chamber open-circuit 
calorimeter (Oxymax Series; Columbus Instruments, Columbus, OH, USA). Pre-weighed mice 
were housed individually in specially built Plexiglas cages (20.1 × 10.1 × 12.7 cm). 
Temperature was maintained at 22 °C with airflow of 0.6 l min–1. Food and water were 
available ad libitum. Mice were singly housed 3 days before transferring into Plexiglas cages 
and were acclimatized to the cages for 24 h before recordings commenced. Mice were 
subsequently monitored in the system for 24 h. Oxygen consumption (VO2) and carbon 
dioxide production (VCO2) were measured every 27 min. The RER was calculated as the 
quotient of VCO2/VO2, with the value of 1 representing 100% carbohydrate oxidation and the 
value of 0.7 representing 100% fat oxidation.bib4040, bib4141 Energy expenditure (kcal heat 
produced) was calculated as calorific value (CV) × VO2, where CV is 3.815+1.232 × 
RER.bib4242 Data for the 24-h monitoring period was averaged for 1-h intervals for energy 
expenditure and RER. 
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Measurement of physical activity 
Ambulatory activity of individually housed mice was evaluated within the metabolic chambers 
using an OPTO-M3 sensor system (Columbus Instruments), whereby ambulatory counts were 
a record of consecutive adjacent photo-beam breaks. Cumulative ambulatory counts of X and 
Y directions were recorded every minute and summed for 1-h intervals. 
 
Analysis of body composition 
On completion of indirect calorimetry and physical activity measurements, animals were 
anesthetized with isoflurane and then scanned using dual-energy X-ray absorptiometry (Lunar 
PIXImus2 mouse densitometer; GE Healthcare, Waukesha, WI, USA) to determine whole body 
lean and fat mass. The head and the tail were excluded from the analysis of body composition. 
 
Serum insulin and free fatty acid analyses 
Serum insulin and free fatty acid levels were determined with an Insulin ELISA from Linco 
Research (St Louis, MO, USA) and a kit from Wako (Osaka, Japan), respectively. 
 
Western blotting 
Western blotting was performed on liver and quadriceps muscle samples following procedures 
described earlierbib4343 to determine protein levels of key enzymes involved in mitochondrial 
oxidation. Briefly, liver and powdered muscle samples were resuspended in radio-
immunoprecipitation assay buffer (PBS, pH 7.5; 1% non-ident NP-40; 0.5% sodium deoxy-
cholate and 0.1% SDS), supplemented with protease and phosphatase inhibitors (10 µg ml–1 
phenylmethylsulfonyl fluoride, 10 µg ml–1 aprotinin, 10 µg ml–1 leupeptin, 1 mmol l–1 
Na3VO4 and 10 mmol l–1 NaF) and solubilized for 2 h at 4 °C. Equal amounts of tissue lysate 
(12.5 µg protein) were resolved by SDS–PAGE and immunoblotted with appropriate antibodies 
against peroxisome proliferator-activated receptor γ coactivator (Calbiochem, Merck PTY. 
Kilsyth VIC, Australia), carnitine palmitoyltransferase-1 (CPT-1) (Alpha Diagonistic Intl. Inc., 
San Antonio, TX, USA) and an antibody cocktail that recognizes several subunits of the 
mitochondrial respiratory chain (MS601; Mitosciences, Eugene, OR, USA). Immunolabelled 
bands were quantitated by densitometry. Relative protein levels of the mutant mice as a 
percentage of that of control mice are presented. 
 
Enzyme activity measurements 
Liver and powdered muscle samples were homogenized 1:19 (wt/vol) in 50 mmol l–1 Tris–
HCl, 1 mmol l–1 EDTA and 0.1% Triton X-100, pH 7.2, using a Polytron instrument 
(Kinematica, Littau-Lucerne, Switzerland) and were subjected to three freeze-thaw cycles. 
Activity of key enzymes involved in lipid oxidation including citrate synthase, β-hydroxyacyl 
CoA dehydrogenase (βHAD), medium-chain acyl-CoA dehydrogenase (MCAD) and cytochrome 
c oxidase were determined at 30 °C, as described earlierbib4343, bib4444, bib4545 using a Spectra 
Max 250-microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). Enzyme 
activities were expressed as units per gram wet weight of tissue, in which units are defined as 
micro-moles per minutes. Relative enzyme activities of the mutant mice as a percentage of 
that of control mice are presented. 
 
RNA extraction and quantitative real-time PCR 
To determine the Y1-receptor deletion efficiency in conditional Y1-receptor-knockdown mice, 
we measured Y1-receptor mRNA expression levels in liver and brain tissues from conditional 
Y1-receptor-knockdown and control mice. Total RNA from liver and the hypothalamic region of 
the brain was extracted using TRIzol reagent (Sigma, St Louis, MO, USA) following the 
manufacturer's protocol. The quality and concentration of RNA was determined by measuring 
the absorbance at 260 and 280 nm using a spectrophotometer (NanoDrop 1000, NanoDrop 
Technologies, LLC, Wilmington, DE, USA), and RNA integrity was confirmed by agarose gel 
electrophoresis. One microgram of total RNA was taken for DNase treatment (RQ1 RNase-Free 
DNase, Promega, Madison, WI, USA) to remove genomic DNA contamination. Subsequently, 
cDNA was synthesized with oligo(dT)20 and random hexamers using Superscript III First-
strand Synthesis System for reverse transcription-PCR (Invitrogen, Mount Waverley, VIC, 
Australia). Quantitative real-time PCR was then carried out on an ABI Prism 7900 HT 
instrument (Applied Biosystems Inc., Foster City, CA, USA) using the TaqMan Universal PCR  
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master mix (Applied Biosystems Inc.) following the manufacturer's instructions. Probes and 
primers for the target gene, the Y1 receptor (Mm00650798_g1) and the reference gene, β-
actin (Mm00697939_s1), were selected from TaqMan gene expression assay reagents (Applied 
Biosystems Inc.). Fluorescent signals generated during PCR amplifications were monitored and 
analysed with ABI Prism 7900 HT SDS software (Applied Biosystems Inc.). To determine the 
efficiency of each TaqMan gene expression assay, standard curves were generated by serial 
dilution of cDNA, and quantitative evaluations of target and reference gene levels were 
obtained by measuring threshold cycle numbers (Ct). The relative expression of target mRNA 
was computed from the Y1 Ct values and the β-actin Ct value using the standard curve 
method (Sequence Detection Systems Chemistry Guide, Applied Biosystems Inc.). 
 
Radio-ligand binding assay 
Receptor radio-ligand binding assays were conducted as described earlier.bib3636 Briefly, 
20 µm-coronal slides were cut from frozen mouse brains and thaw mounted on charged 
slides. Matching brain sections from the same portion of the hippocampus (−1.94 mm from 
Bregma) were collected. Slides were thawed and pre-incubated at room temperature for 
30 min in Krebs–Henseleit–Tris buffer (118 mm NaCl, 4.8 mm KCl, 1.3 mm MgSO4, 1.2 mm 
CaCl2, 50 mm glucose, 15 mm NaHCO3, 1.2 mm KH2PO4, 10 mm Tris, pH 7.4). Slides were 
then incubated with Krebs–Henseleit–Tris buffer supplemented with 0.1% bovine serum 
albumin, 0.5% bacitracin and 25pM 125I-PYY (PerkinElmer Life Sciences, Inc., Boston, MA, 
USA) for 2 h at room temperature. To determine the expression level of Y1 receptors, the 
addition of 1229U91 (a ligand specific for Y1 receptors; NeoMPS S.A., Strasbourg, France) at 
1 µm was added to compete with 125I-PYY binding. Non-specific binding was determined in the 
presence of 1 µm PYY. The sections were washed by dipping twice in ice-cold Krebs–
Henseleit–Tris buffer and once in ice-cold deionized water followed by air drying. Finally, the 
slides were developed by exposure to βmax films (Kodak, Rochester, NY, USA) for 4 days at 
−80 °C. The autoradiograms were developed and scanned. The relative optical density was 
determined in the dentate gyrus of the hippocampusbib4646 using software from ImageJ 
(ImageJ 1.38x, NIH, Bethesda, MD, USA). Specific binding was calculated by subtracting non-
specific binding from total binding. Non-specific labelling was uniform and never exceeded 5% 
of total signal. 
 
Statistical analyses 
All data are expressed as means±s.e.m. RER and physical activity over the continuous 24-h 
period were averaged for the whole 24-h period, as well as for the light and dark periods. 
Differences between knockout and wild-type mice were assessed by ANOVA or repeated-
measures ANOVA. Comparisons of energy expenditure (kcal h–1) were carried out by analysis 
of covariance with lean body mass and fat mass as the covariates. The adjusted means of 
energy expenditure at a common lean mass and fat mass for the comparison were generated 
by analysis of covariance. Statistical analyses were performed with SPSS for Mac OS X, 
version 16.0.1 (SPSS Inc., Chicago, IL, USA). Statistical significance was defined as P<0.05. 
 
RESULTS 
 
Germline lack of Y1 signalling significantly increases lipid oxidation and physical 
activity independently of obesity 
Body weight (tbl1Table 1) and 24-h food intake (data not shown) were not significantly 
different between Y1−/− and wild-type mice in both genders at 15 weeks of age (tbl1Table 1). 
Interestingly, while male Y1−/− mice at this age showed a slightly, but significantly reduced 
adiposity, female Y1−/− mice had a whole body adiposity double that of wild-type mice 
(tbl1Table 1). Furthermore, serum insulin and free fatty acid levels were significantly 
increased in female Y1−/− mice, but male Y1−/− mice only showed a trend to increased serum 
insulin and free fatty acids (tbl1Table 1). Despite the striking sex difference in body 
composition, both male and female Y1−/− mice showed significant increases in physical activity 
during the dark and light periods relative to controls (tbl1Table 1) without significant changes 
in energy expenditure (tbl1Table 1), suggesting that basal metabolic rate is decreased in the 
knockout mice. Importantly, compared with wild-type controls, both male and female Y1−/− 
mice had significantly decreased RER (tbl1Table 1), suggesting greater use of lipid as an 
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oxidative fuel to provide energy. As obesity is often associated with increased fatty acid influx 
to metabolically active tissues and subsequently increases lipid oxidation,bib4343 the reduced 
RER observed in obese 15-week-old female Y1−/− mice with significantly elevated serum free 
fatty acids levels (tbl1Table 1) raises the possibility that their increased lipid oxidation may be 
secondary to the increased adiposity rather than a primary effect of Y1 deletion. 
 
 
       Thus, to investigate the primary effects of Y1-receptor deletion on energy metabolism in 
the absence of obesity, particularly in female mice, we examined Y1−/− mice at a younger age, 
before the onset of obesity. Both male and female Y1−/− mice at 9 weeks of age weighed 
significantly less than wild-type controls despite no significant change in daily food intake or 
daily faecal output (tbl2Table 2). Furthermore, while 9-week-old male Y1−/− mice exhibited a 
lean phenotype compared with matched wild types, as was also seen in 15-week-old male 
Y1−/− mice, 9-week-old female Y1−/− had a similar level of adiposity to that of age-matched 
female wild-type mice, as evidenced by a similar whole body fat mass as determined by dual-
energy X-ray absorptiometry and the weight of dissected adipose tissue depots (tbl2Table 2). 
Moreover, both male and female Y1−/− mice at 9 weeks of age were not different from their 
gender- and age-matched wild-type controls in regards to circulating insulin or free fatty acid 
levels (tbl2Table 2). Importantly, 9-week-old male and female Y1−/− mice showed a pattern of 
changes in physical activity, energy expenditure and RER that was broadly similar to that seen 
in 15-week-old Y1−/− mice, in that physical activity was significantly increased without changes 
in energy expenditure, and RER was significantly decreased (fig1Figure 1), indicative of 
increased lipid oxidation. It is interesting that the increases in physical activity and lipid 
oxidation seen in female Y1−/− versus wild-type mice seems more pronounced at 15 than at 9 
weeks of age, as differences between genotypes in these parameters were significant in both 
the dark and light phases in the older female Y1−/− mice (tbl1Table 1), but were only 
significant in one phase in the younger female Y1−/− mice (fig1Figures 1b and f). Therefore, 
the more significant increases in physical activity and lipid oxidation seen in the older obese 
female Y1−/− mice may be due to compensatory responses to increase adiposity, in addition to 
primary effects of Y1-receptor deletion on these parameters as seen in younger non-obese 
male and female Y1−/− mice. 
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Taken together, these data show that germline Y1-receptor
deletion in both male and female mice leads to increased
lipid oxidation and physical activity without significant
Table 1 Effects of germline Y1 deletion on body composition, serum parameters and energy metabolism in mice at 15 weeks of age
Parameter Male Female
Wild type Y1!/! Wild type Y1!/!
Body weight (g) 30.5±1.0 27.5±1.0 22.6±0.5 22.7±0.7
Whole body fat mass (% BW) 22.79±0.81 17.52±0.8* 18.19±0.9 34.23±1.18*
Serum insulin (pM) 148.9±30.1 219.6±50.9 99.4±11.3 185.3±31.1*
Serum FFA (mEq l–1) 1.55±0.13 2.18 + 0.27 0.86±0.09 1.66±0.19*
Physical activity (ambulatory counts per hour)
24h 311±53 600±83* 534±77 1064±208*
Dark phase 481±85 917±142* 808±153 1554±327*
Light phase 141±24 282±43* 260±34 575±131*
Energy expenditure (kcal per hour)
24h 0.458±0.01 0.440±0.02 0.408±0.02 0.377±0.04
Dark phase 0.483±0.01 0.481±0.02 0.435±0.02 0.403±0.05
Light phase 0.433±0.01 0.398±0.02 0.382±0.02 0.350±0.04
Respiratory exchange ratio
24h 1.01±0.02 0.957±0.02 (P¼ 0.06) 1.01±0.02 0.936±0.01**
Dark phase 1.03±0.01 1.01±0.02 1.03±0.01 0.962±0.01*
Light phase 0.983±0.02 0.901±0.01* 1.00±0.02 0.909±0.03**
Abbreviations: BW, body weight; FFA, free fatty acid. Whole body fat mass was determined by dual-energy X-ray absorptiometry. Physical activity, energy
expenditure and respiratory exchange ratio were determined in metabolic chamber and expressed as averages for 24-h, dark (1900–0700h) and light
(0700–1900 h) periods. For comparison of energy expenditure by analysis of covariance, common lean and fat mass are 21.58 and 5.74 g, respectively, for male
mice and 16.63 and 5.08 g, respectively, for female mice. Data are means±s.e.m. of 6–10 mice per group. *Po0.05 and **Po0.001 versus gender-matched wild-
type mice.
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changes in energy expenditure. Although female Y1!/!mice
developed obesity at 15 weeks of age, these changes in
energy metabolism are the primary effects of germline
Y1-receptor deletion as non-obese male Y1!/! and younger
female Y1!/! mice showed the same effects.
Altered muscle and liver mitochondria function in Y1!/! mice
To determine the mechanisms by which Y1 deletion might
increase fat oxidation, we investigated key mitochondrial
functions that control lipid oxidation. By western blotting
of muscle and liver extracts, we determined the protein
levels of CPT-1, the mitochondrial transmembrane enzyme
controlling entry of fatty acid into mitochondria and the
rate-limiting enzyme for fatty acid oxidation.47,48 There was
a 1.3- to 1.6-fold increase in the protein levels of CPT-1 in the
muscle and liver of 9-week-old male and female Y1!/! mice
compared with wild-type mice (Figures 2a and b), showing
increased capacity for transporting fatty acids into mito-
chondria for oxidation. To examine mitochondrial fatty acid
utilization at a functional level, we also determined the
maximal activity of key enzymes of the b-oxidation pathway,
namely, bHAD and MCAD in muscle tissue. The maximal
activities of bHAD and MCAD in muscle from Y1!/! mice of
both genders were increased relative to wild-type controls
(Figures 2c and d), although the increase in muscle bHAD
activity from male Y1!/! mice did not reach statistical signif-
icance. This shows enhanced capacity for b-oxidation of
fatty acids in Y1!/! mice. Taken together, these data show
that lack of Y1 signalling is associated with increased capacity
for mitochondrial fatty acid transport and b-oxidation, which
is likely the major contributor to the increased lipid
oxidation indicated by the reduced RER seen in Y1!/! mice.
Male Y1!/! mice exhibit greater muscle mitochondrial
oxidative capability
Having seen an increased capacity for fatty acid transport
and oxidation in Y1 deficiency, we subsequently investigated
whether the overall mitochondrial oxidative capability is
also increased by Y1 deletion. Thus, we examined the muscle
protein levels of several subunits of the mitochondrial
respiratory chain complexes (I, II, III and V) by western
blotting, as well as peroxisome proliferator-activated recep-
tor g coactivator 1a, (PGC-1a) an important regulator of
mitochondrial biogenesis.49 The protein levels of subunits of
the respiratory chain complex I, II III and V were all
significantly increased in the muscle of 9-week-old male,
but not female Y1!/!mice compared with wild-type controls
(Figures 2e and f). In addition to the increased level of
Table 2 Effects of germline Y1 deletion on body composition, serum and feeding parameters and energy metabolism in mice at 9 weeks of age
Parameter Male Female
Wild type Y1!/! Wild type Y1!/!
Body weight (g) 24.3±0.4 22.1±0.5* 19.6±1.2 15.2±0.6*
Daily food intake (g) 3.58±0.19 3.69±0.13 2.92±0.11 2.83±0.19
Daily faecal output (g) 0.98±0.11 0.98±0.10 0.74±0.07 0.65±0.08
Whole body fat mass (% BW) 15.25±1.38 11.68±0.30* 14.57±0.86 15.77±0.77
Inguinal WAT (% BW) 1.436±0.122 1.035±0.082* 1.813±0.215 2.06±0.068
Epididymal WAT (% BW) 1.419±0.112 0.960±0.115* 1.488±0.274 1.440±0.094
Mesenteric WAT (% BW) 0.741±0.066 0.415±0.059* 0.953±0.147 0.586±0.064*
Retroperitoneal WAT (% BW) 0.375±0.034 0.245±0.037* 0.217±0.039 0.457±0.025*
Serum insulin (pM) 108.1±10.5 110.1±20.3 96.4±2.3 77.7±12.0
Serum FFA (mEq l–1) 1.31±0.32 0.92±0.15 1.07±0.01 0.75±0.35
Physical activity (ambulatory counts per hour)
24-h 777±114 957±134 846±116 1124±285
Dark phase 1235±202 1220±212 1408±219 1709±499
Light phase 319±49 697±110* 285±52 539±107*
Energy expenditure (kcal per hour)
24-h 0.418±0.01 0.405±0.011 0.374±0.009 0.396±0.014
Dark phase 0.459±0.011 0.424±0.012 0.408±0.011 0.432±0.017
Light phase 0.377±0.01 0.385±0.011 0.339±0.011 0.360±0.016
Respiratory exchange ratio
24-h 0.994±0.016 0.938±0.014* 0.998±0.011 0.939±0.025*
Dark phase 1.03±0.013 0.987±0.022 1.04±0.009 0.988±0.033
Light phase 0.957±0.021 0.889±0.016* 0.955±0.017 0.889±0.018*
Abbreviations: BW, body weight; FFA, free fatty acid; WAT, white adipose tissue. Whole body fat mass determined by dual-energy X-ray absorptiometry and weight
of individual WAT depots were expressed as percentage of BW. For comparison of energy expenditure by analysis of covariates, common lean mass and fat mass
were 17.7 and 2.8 g for male and 13.9 and 2.7 g for female mice, respectively. Data are means±s.e.m. of 5–9 mice per group. *Po0.05 versus gender-matched
wild-type mice.
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mitochondrial respiratory chain complex proteins, male
Y1!/! mice had a 1.7-fold increase in muscle protein levels
of PGC-1a compared with male wild-type mice, whereas no
such increase was seen in female Y1!/! mice (Figure 2g).
These data suggest an increased mitochondrial oxidative
capacity in male Y1!/! mice. To examine the mitochondrial
oxidative capacity at a functional level, we also determined
in muscle tissue the maximal activity of citrate synthase, a
key enzyme of the Krebs cycle, and cytochrome c oxidase,
representing complex IV of the respiratory chain. Although
both male and female Y1!/! mice showed a significant
increase in muscle citrate synthase activity (Figure 2h), only
male Y1!/! mice had significantly increased cytochrome c
oxidase activity compared with corresponding wild-type
controls (Figure 2i). Collectively, these data suggest that Y1
deficiency in male mice leads to increased mitochondrial
oxidative capacity, whereas this effect in female mice is
absent or less pronounced. This gender difference in changes
in mitochondrial oxidative capacity because of Y1 deletion
may contribute to the difference in adiposity observed
between male and female Y1!/! mice.
Increased lipid oxidation in Y1 deficiency involves
peripheral Y1 receptors
To study the possible function of peripherally expressed Y1
receptors in the control of energy metabolism, we generated
a conditional Y1-receptor-knockdown mouse model in
which partial deletion of Y1 receptors was induced specifi-
cally in peripheral tissues of adult mice. This was achieved by
crossing mice harbouring the Y1-receptor gene flanked by
recombinase recognition (LoxP) sites (Y1lox/lox) onto trans-
genic mice expressing Cre-recombinase under the control of
interferon-responsive Mx1 promoter. PCR on gemonic DNA
shows that the Mx1-activated Cre-mediated Y1-gene partial
deletion was achieved in the hypothalamus as well as in
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 Taken together, these data show that germline Y1-receptor deletion in both male and 
female mice leads to increased lipid oxidation and physical activity without significant changes 
in energy expenditure. Although female Y1−/− mice developed obesity at 15 weeks of age, 
these changes in energy metabolism are the primary effects of germline Y1-receptor deletion 
as non-obese male Y1−/− and younger female Y1−/− mice showed the same effects. 
 
Altered muscle and liver mitochondria function in Y1−/− mice 
To determine the mechanisms by which Y1 deletion might increase fat oxidation, we 
investigated key mitochondrial functions that control lipid oxidation. By western blotting of 
muscle and liver extracts, we determined the protein levels of CPT-1, the mitochondrial 
transmembrane enzyme controlling entry of fatty acid into mitochondria and the rate-limiting 
enzyme for fatty acid oxidation.bib4747, bib4848 There was a 1.3- to 1.6-fold increase in the 
protein levels of CPT-1 in the muscle and liver of 9-week-old male and female Y1−/− mice 
compared with wild-type mice (fig2Figures 2a and b), showing increased capacity for 
transporting fatty acids into mitochondria for oxidation. To examine mitochondrial fatty acid 
utilization at a functional level, we also determined the maximal activity of key enzymes of the 
β-oxidation pathway, namely, βHAD and MCAD in muscle tissue. The maximal activities of 
βHAD and MCAD in muscle from Y1−/− mice of both genders were increased relative to wild-
type controls (fig2Figures 2c and d), although the increase in muscle βHAD activity from male 
Y1−/− mice did not reach statistical significance. This shows enhanced capacity for β-oxidation 
of fatty acids in Y1−/− mice. Taken together, these data show that lack of Y1 signalling is 
associated with increased capacity for mitochondrial fatty acid transport and β-oxidation, 
which is likely the major contributor to the increased lipid oxidation indicated by the reduced 
RER seen in Y1−/− mice. 
 
Male Y1−/− mice exhibit greater muscle mitochondrial oxidative capability 
Having seen an increased capacity for fatty acid transport and oxidation in Y1 deficiency, we 
subsequently investigated whether the overall mitochondrial oxidative capability is also 
increased by Y1 deletion. Thus, we examined the muscle protein levels of several subunits of 
the mitochondrial respiratory chain complexes (I, II, III and V) by western blotting, as well as 
peroxisome proliferator-activated receptor γ coactivator 1α, (PGC-1α) an important regulator 
of mitochondrial biogenesis.bib4949 The protein levels of subunits of the respiratory chain 
complex I, II III and V were all significantly increased in the muscle of 9-week-old male, but 
not female Y1−/− mice compared with wild-type controls (fig2Figures 2e and f). In addition to 
the increased level of mitochondrial respiratory chain complex proteins, male Y1−/− mice had a 
1.7-fold increase in muscle protein levels of PGC-1α compared with male wild-type mice, 
whereas no such increase was seen in female Y1−/− mice (fig2Figure 2g). These data suggest 
an increased mitochondrial oxidative capacity in male Y1−/− mice. To examine the 
mitochondrial oxidative capacity at a functional level, we also determined in muscle tissue the 
maximal activity of citrate synthase, a key enzyme of the Krebs cycle, and cytochrome c 
oxidase, representing complex IV of the respiratory chain. Although both male and female 
Y1−/− mice showed a significant increase in muscle citrate synthase activity (fig2Figure 2h), 
only male Y1−/− mice had significantly increased cytochrome c oxidase activity compared with 
corresponding wild-type controls (fig2Figure 2i). Collectively, these data suggest that Y1 
deficiency in male mice leads to increased mitochondrial oxidative capacity, whereas this 
effect in female mice is absent or less pronounced. This gender difference in changes in 
mitochondrial oxidative capacity because of Y1 deletion may contribute to the difference in 
adiposity observed between male and female Y1−/− mice. 
 
Increased lipid oxidation in Y1 deficiency involves peripheral Y1 receptors 
To study the possible function of peripherally expressed Y1 receptors in the control of energy 
metabolism, we generated a conditional Y1-receptor-knockdown mouse model in which partial 
deletion of Y1 receptors was induced specifically in peripheral tissues of adult mice. This was 
achieved by crossing mice harbouring the Y1-receptor gene flanked by recombinase 
recognition (LoxP) sites (Y1lox/lox) onto transgenic mice expressing Cre-recombinase under the 
control of interferon-responsive Mx1 promoter. PCR on gemonic DNA shows that the Mx1- 
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activated Cre-mediated Y1-gene partial deletion was achieved in the hypothalamus as well as 
in various peripheral tissues and organs (fig3Figure 3a), consistent with an earlier report.bib3939 
Importantly, no detectable change in Y1-mRNA expression was seen in the hypothalamic 
region of the brain of conditional Y1-receptor-knockdown mice compared with that of control 
mice, as quantitated by quantitative real-time PCR (fig3Figure 3b), in keeping with an earlier 
study showing poor Mx1-activated Cre-mediated gene deletion in the brain.bib3939 In contrast, 
a significant reduction of Y1-mRNA expression was seen in the liver of conditional Y1-receptor-
knockdown mice (fig3Figure 3b), in which it is known that Mx1-activated Cre-mediated gene 
deletion has the highest efficiency.bib3939 To confirm the unchanged expression levels of central 
Y1 receptors in our conditional knockdown mice at a functional protein level, we performed 
competitive autoradiography on brain sections using a Y1-selective ligand, 1229U91,bib5050 to 
compete with 125I-PYY binding. The 125I-PYY-binding intensity, with or without 1229U91 as a 
competitor, was analysed in the dentate gyrus of the hippocampus in which Y1 receptors are 
highly expressed.bib3636 The total specific 125I-PYY-binding intensity in the dentate gyrus of 
conditional Y1-receptor-knockdown mice was similar to that of control mice (fig3Figure 3c), 
suggesting that the functional protein levels of total Y receptors are not changed in the brain 
of these animals. Furthermore, the percentage of 125I-PYY binding displaced by 1229U91 in the 
dentate gyrus area was comparable between conditional knockdown and control mice 
(fig3Figure 3d), indicating a similar proportion of Y1 receptors expressed in the dentate gyrus 
of both groups. These radio-ligand binding data suggest unaltered central Y1-receptor 
expression in conditional Y1-knockdown mice, consistent with the real-time PCR results 
presented in fig3Figure 3b. 
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Figure 2 Mitochondrial oxidation in germline Y1!/!mice. Protein levels of CPT-1 in muscle (a) and liver (b), and maximal activity of muscle bHAD (c) and MCAD
(d), muscle protein levels of mitochondrial respiratory chain complexes I, II, III and V (e, f) and peroxisome proliferator-activated receptor (PPAR) g coactivator -1a
(PGC-1a, g), maximal activity of citrate synthase (CS, h) and cytochrome c oxidase (COX, i) in wild type (WT) and Y1!/! at 9 weeks of age. Data are means±s.e.m.
of 5–8 mice per group and are expressed as a percentage of WT values. *Po0.05 versus gender-matched WT.
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Having established a conditional Y1-knockdown model in which Y1 receptors are only 
deleted in peripheral tissues, we investigated energy metabolism in these mice 5 weeks after 
induction of Y1-gene deletion. The conditional Y1-knockdown mice exhibited similar body 
weight, daily food intake and faecal output, body composition, and circulating levels of insulin 
and free fatty acids as well as rectal temperature compared with corresponding measures in 
control mice (tbl3Table 3). Furthermore, the conditional Y1 knockdown in peripheral tissues of 
adult mice had no effect on physical activity (fig3Figure 3e; tbl3Table 3) or energy 
expenditure (fig3Figure 3f; tbl3Table 3), suggesting that the increased physical activity seen 
in germline Y1−/− mice (tbl1Table 1; fig1Figures 1a and b) is due to a lack of central Y1 
signalling. Importantly, however, the conditional Y1 knockdown in mice induced a significantly 
reduced RER during the light period (fig3Figure 3g; tbl3Table 3), showing an important 
function of peripheral Y1 receptors in the regulation of oxidative fuel selection. Furthermore, 
consistent with an increased lipid oxidation, conditional Y1 knockdown in mice induced a 1.4-
fold increase in hepatic CPT-1 protein levels (protein levels of CPT-1 as percentage of control 
mice: 100±7 and 140.7±13% for control and conditional Y1-knockdown mice, respectively, 
data are mean±s.e.m. of 5–7 mice for each group; P<0.05) and a moderate, but significant 
increase in maximal hepatic activity of βHAD (activity as percentage of control mice: 100±5.7 
and 118±2.5% for control and conditional Y1-knockdown mice, respectively, data are 
mean±s.e.m. of 4–6 mice per group, P<0.05). These data show that similar to germline Y1-
receptor deletion, peripheral Y1-receptor knockdown leads to increased lipid oxidation without 
changes in energy expenditure, showing the important function of peripheral Y1 receptors in 
the regulation of oxidative fuel selection. Furthermore, in contrast to the significant increase in 
physical activity seen in germline Y1-receptor-knockout mice, peripheral Y1-receptor 
knockdown did not alter physical activity. This suggests an important function of central Y1 
receptors in the regulation of physical activity. 
knockdown and control mice (Figure 3d), indicating a
similar proportion of Y1 receptors expressed in the dentate
gyrus of both groups. These radio-ligand binding data
suggest unaltered central Y1-receptor expression in condi-
tional Y1-knockdown mice, consistent with the real-time
PCR results presented in Figure 3b.
Having established a conditional Y1-knockdown model in
which Y1 receptors are only deleted in peripheral tissues, we
investigated energy metabolism in these mice 5 weeks after
induction of Y1-gene deletion. The conditional Y1-knock-
down mice exhibited similar body weight, daily food intake
and faecal output, body composition, and circulating levels
of insulin and free fatty acids as well as rectal temperature
compared with corresponding measures in control mice
(Table 3). Furthermore, the conditional Y1 knockdown in
peripheral tissues of adult mice had no effect on physical
a tivity (Figure 3e; T ble 3) or energy expenditure (Figure 3f;
Tab e 3), suggesting t at the increased hysical activity seen
in germline Y1!/!mice (Table 1; Figures 1a and b) is due to a
lack of central Y1 signalling. Importantly, however, the
conditional Y1 knockdown in mice induced a significantly
reduced RER during the light period (Figure 3g; Table 3),
showing an important function of peripheral Y1 receptors in
the regulation of oxidative fuel selection. Furthermore,
consistent with an increased lipid oxidation, conditional
Y1 knockdown in mice induced a 1.4-fold increase in hepatic
CPT-1 protein levels (protein levels of CPT-1 as percentage of
control mice: 100±7 and 140.7±13% for control and
conditional Y1-knockdown mice, respectively, data are
mean±s.e.m. of 5–7 mice for each group; Po0.05) and a
moderate, but significant increase in maximal hepatic
activity of bHAD (activity as percentage of control mice:
100±5.7 and 118±2.5% for control and conditional
Y1-knockdown mice, respectively, data are mean±s.e.m. of
4–6 mice per group, Po0.05). These data show that similar to
germline Y1-receptor deletion, peripheral Y1-receptor knock-
down leads to increased lipid oxidation without changes in
energy expenditure, showing the important function of
peripheral Y1 receptors in the regulation of oxidative fuel
selection. Furthermore, in contrast to the significant increase
in physical activity seen in germline Y1-receptor-knockout
mice, peripheral Y1-receptor knockdown did not alter
physical activity. This suggests an important function of
central Y1 receptors in the regulation of physical activity.
Peripheral Y1-receptor deletion protects against
diet-induced obesity
To examine whether peripheral Y1-receptor knockdown and
the resultant increase in lipid oxidation had functional
effects to protect against diet-induced obesity, we challenged
conditional Y1-knockdown mice with an ad libitum high fat
diet for 21 weeks. Basal body weight determined before the
commencement of high fat feeding was comparable between
conditional Y1 knockdown and controls (20.7±0.5 and
20.0±0.8 g for control and conditional Y1-knockdown mice,
respectively; means±s.e.m. of 5 mice per group; NS).
Interestingly, conditional Y1-knockdown mice on a high
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Figure 3 Unaltered brain Y1-receptor expression in peripheral conditional Y1-knockdown mice and subsequent effects on energy metabolism. (a) Mx1-activated Cre-
mediated Y1-gene deletion was assessed by PCR on genomic DNA isolated from conditional Y1-knockdown and control mice; primer sets A and B give PCR product in
the absence and presence of Y1-gene deletion, respectively. (b) Y1 mRNA expression levels in the hypothalamic region of the brain and liver of conditional Y1-
knockdown versus control mice. Intensity of specific 125I-PYY binding (c) and the percentage of 125I-PYY binding displaced by the Y1-selective ligand (1229U91) (d)
were examined in the dentate gyrus region of the brain of conditional Y1-knockdown and control mice. Physical activity (e), energy expenditure (f) and respiratory
exchange ratio (g) were determined in metabolic chamber. For comparison of energy expenditure by analysis of covariance, common lean mass and fat mass were 14.3
and 5.1g, respectively. Open and grey bars indicate light and dark phases, respectively. Data are means±s.e.m. of 4–6 mice per group. *Po0.05 versus control mice.
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Peripheral Y1-receptor deletion protects against diet-induced obesity 
To examine whether peripheral Y1-receptor knockdown and the resultant increase in lipid 
oxidation had functional effects to protect against diet-induced obesity, we challenged 
conditional Y1-knockdown mice with an ad libitum high fat diet for 21 weeks. Basal body 
weight determined before the commencement of high fat feeding was comparable between 
conditional Y1 knockdown and controls (20.7±0.5 and 20.0±0.8 g for control and conditional 
Y1-knockdown mice, respectively; means±s.e.m. of 5 mice per group; NS). Interestingly, 
conditional Y1-knockdown mice on a high fat diet showed significantly reduced weight gain 
compared with controls (fig4Figure 4a). Importantly, this reduced weight gain in the 
conditional knockdown mice was associated with no difference in daily food intake or faecal 
output and a significant reduction in whole body fat mass without any changes in lean mass as 
determined by dual-energy X-ray absorptiometry scan after 15 weeks of high fat diet 
(tbl4Table 4). Moreover, when individual white adipose tissue depots were dissected out and 
weighed after 21 weeks on the high fat diet, the conditional Y1-knockdown mice showed 
significant reductions in the absolute weight of all dissected white adipose tissue depots 
investigated (namely, the inguinal, epididymal, retroperitoneal and mesenteric white adipose 
tissue depots) (fig4Figure 4b) as well as the summed weight of these tissues (fig4Figure 4c). 
In addition, the summed or individual weights of white adipose tissue depots as a percentage 
of body weight was decreased in conditional Y1-knockdown mice, albeit this decrease did not 
reach statistical significance for the inguinal and retroperitoneal depots (fig4Figures 4d and e). 
Interestingly, the significantly reduced adiposity in conditional Y1-knockdown mice on the high 
fat diet occurred in the absence of significant effects on serum insulin, overall physical activity  
fat diet showed significantly reduced weight gain compared
with controls (Figure 4a). Importantly, this reduced weight
gain in the conditio al knockdown mice was associated ith
no difference in daily food intake or faecal output and a
significant reduction in whole body fat mass without any
changes in lean mass as determined by dual-energy X-ray
absorptiometry scan after 15 weeks f high fat diet (Table 4).
Moreover, when individual white adipose tissue depots were
dissected out and weighed after 21 weeks on the high fat
diet, the conditional Y1-knockdown mice showed significant
reductions in the absolute weight of all dissected white
adipose tissue depots investigated (namely, the inguinal,
epididymal, retroperitoneal and mesenteric white adipose
tissue depots) (Figure 4b) as well as the summed weight of
these tissues (Figure 4c). In addition, the summed or
individual weights of white adipose tissue depots as a
percentage of body weight was decreased in conditional
Y1-knockdown mice, albeit this decrease did not reach
statistical significance for the inguinal and retroperitoneal
depots (Figures 4d and e). Interestingly, the significantly
reduced adiposity in conditional Y1-knockdown mice on the
high fat diet occurred in the absence of significant effects on
serum insulin, overall physical activity or rectal temperature
compared with corresponding measures in control mice
(Table 4). Although there was no significant difference in
energy expenditure between the knockdown and control
mice on the high fat diet (Table 4), the conditional
Y1-knockdown animals had generally higher energy expen-
diture than controls, with total 24-h energy expenditure
being B6% higher in knockout mice (Table 4). Notably,
conditional Y1-knockdown mice on the high fat diet showed
a decrease in RER relative to control mice during the light
period (P¼0.07) (Figure 4f), suggesting that higher lipid
oxidation could contribute to the reduced fat gain in
conditional Y1-knockdown mice during high fat feeding.
It is important to note that high fat feeding itself increases
lipid oxidation,26,51–53 and this is evident in this study in
which the average 24-h RER of chow-fed control mice is
1.02±0.02 compared with 0.89±0.02 in control mice fed on
a high fat diet (means±s.e.m. of 3–5 mice per group,
Po0.05). A similar difference in RER is seen between chow-
versus fat-fed conditional Y1-knockdown mice; 0.95±0.03
versus 0.85±0.05, respectively (means±s.e.m. of 3–5 mice
per group, Po0.05). Therefore, the significant decrease in
RER seen in chow-fed conditional Y1-knockdown versus
control mice (Figure 3g) may have been masked by the
effects of the high fat diet per se during the high fat diet. In
summary, these data show that mice with conditional
Y1-receptor knockdown are resistant to diet-induced obesity,
and this effect may be attributable to increased lipid
oxidation.
Discussion
This study shows that the regulation of oxidative fuel
selection and physical activity is critically dependent on Y1
signalling, as germline lack of Y1 receptors resulted in a
reduction in RER, consistent with a preference for lipid as an
oxidative fuel source and a significantly increased physical
activity with no change in energy expenditure. Importantly,
these effects of germline Y1-receptor deletion on energy
metabolism occurred in both male and female mice, but
show differences in the age of onset and the degree of obesity
induced by germline Y1-receptor deletion.23,24 Moreover, the
mechanism behind the greater utilization of lipid as an
oxidative fuel source in mice lacking Y1 receptors most likely
involves increases in hepatic and muscle protein levels of
CPT-1 as well as increases in hepatic and muscle activity of
enzymes involved in b-oxidation, suggesting that Y1-recep-
tor-signalling controls mitochondrial capacity for fatty acid
transport and oxidation. Peripherally expressed Y1 receptors
have a function in mediating these effects, as mice with
conditional knockdown of Y1 receptors, in which Y1-gene
Table 3 Effects of peripheral Y1-receptor knockdown on body composition,
serum and feeding parameters and energy metabolism
Control Conditional Y1
knockdown
Body weight (g) 21.89±0.89 19.66±0.30
Daily food intake (g) 2.86 ±0.10 2.88 ±0.10
Daily faecal output (g) 0.68±0.05 0.62±0.08
Whole body lean mass (g) 14.53±0.39 13.87±0.12
Whole body fat mass (g) 5.57±0.58 4.67±0.15
Whole body fat mass (% BW) 27.63±2.04 25.27±0.74
Inguinal WAT (% BW) 2.88±0.37 2.84±0.16
Epididymal WAT (% BW) 2.81±0.28 3.01±0.16
Retroperitoneal WAT (% BW) 0.77±0.20 0.61±0.03
Mesenteric WAT (% BW) 1.26±0.05 1.15±0.07
Total WAT (% BW) 7.61±0.32 7.61±0.12
Serum insulin (pM) 101.15±18.89 85.22±8.19
Serum free fatty acid (mEq l–1) 1.121±0.078 1.214±±0.184
Rectal temperature (1C) 36.3±0.2 37.0±0.2
Energy expenditure (kcal per hour)
24-h 0.358±0.014 0.374±0.017
Dark phase 0.378±0.02 0.397±0.024
Light phase 0.339±0.009 0.351±0.012
Physical activity (ambulatory counts per hour)
24-h 197±13 171±68
Dark phase 283±14 269±107
Light phase 111±29 72±29
Respiratory exchange ratio
24-h 1.02±0.013 0.95±0.017*
Dark phase 1.06±0.011 1.01±0.027
Light phase 0.986±0.015 0.891±0.016*
Abbreviations: BW, body weight; WAT, white adipose tissue. Whole body lean
and fat masses were determined by dual energy X-ray absorptiometry. Weight
of individual WAT depots was expressed as percentage of BW. For comparison
of energy expenditure by analysis of covariance, common lean mass and fat
mass were 14.3 and 5.1 g, respectively. Data were obtained at 5 weeks after
the commencement of induction of gene deletion and are means±s.e.m. of
4–6 mice per group. *Po0.05 versus control mice.
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or rectal temperature compared with corresponding measures in control mice (tbl4Table 4). 
Although there was no significant difference in energy expenditure between the knockdown 
and control mice on the high fat diet (tbl4Table 4), the conditional Y1-knockdown animals had 
generally higher energy expenditure than controls, with total 24-h energy expenditure being 
~6% higher in knockout mice (tbl4Table 4). Notably, conditional Y1-knockdown mice on the 
high fat diet showed a decrease in RER relative to control mice during the light period 
(P=0.07) (fig4Figure 4f), suggesting that higher lipid oxidation could contribute to the reduced 
fat gain in conditional Y1-knockdown mice during high fat feeding. It is important to note that 
high fat feeding itself increases lipid oxidation,bib2626, bib5151, bib5252, bib5353 and this is evident in 
this study in which the average 24-h RER of chow-fed control mice is 1.02±0.02 compared 
with 0.89±0.02 in control mice fed on a high fat diet (means±s.e.m. of 3–5 mice per group, 
P<0.05). A similar difference in RER is seen between chow- versus fat-fed conditional Y1-
knockdown mice; 0.95±0.03 versus 0.85±0.05, respectively (means±s.e.m. of 3–5 mice per 
group, P<0.05). Therefore, the significant decrease in RER seen in chow-fed conditional Y1-
knockdown versus control mice (fig3Figure 3g) may have been masked by the effects of the 
high fat diet per se during the high fat diet. In summary, these data show that mice with 
conditional Y1-receptor knockdown are resistant to diet-induced obesity, and this effect may 
be attributable to increased lipid oxidation. 
 
 
deletion occurs in a large variety of tissues with the highest
efficiency in liver, but with no effect on Y1-receptor
expression in the brain, led to similar changes in RER and
hepatic CPT-1 and b-oxidative enzyme activity compared
with germline Y1!/! mice. Most importantly from a clinical
perspective, peripheral Y1-receptor knockdown protected
against high fat diet-induced increases in body weight and
total adiposity in the absence of effects on lean mass or
inguinal fat mass. As preservation of lean mass and inguinal
fat during loss of excess adiposity is desirable because of
known beneficial effects of these tissues on metabolic rate
and disease risk,54–58 and as these benefits could be achieved
without the need to deliver Y1 antagonists to the brain, this
finding has significant implications for the pharmacological
management of obesity.
The increased fat oxidation seen in Y1-deficient mice is
likely mediated by increased capacity for fatty acid transport
into mitochondria and increased b-oxidation. Germline and
conditional Y1-receptor-deficient mice exhibit increased
protein levels of CPT-1 in skeletal muscle and/or liver, the
two primary tissues contributing to basal metabolic rate and
major sites of fatty acid oxidation.59–61 CPT-1 is a mitochon-
drial transmembrane enzyme and considered to be rate
limiting for long-chain fatty acid entry into the mitochon-
dria for b-oxidation.62 An increased CPT-1 expression in
Y1-deficient mice suggests an increased capacity for fatty
acid influx into mitochondria, which in itself is sufficient to
increase fat oxidation.63 This is confirmed by the signifi-
cantly increased maximal activities of MCAD and/or b-HAD
in germline and conditional Y1-receptor-knockout mice,
which are key enzymes involved in b-oxidation.64
In addition to increased lipid oxidation, small imbalances
in energy intake versus expenditure may have contributed
to the reduced diet-induced obesity seen conditional
Y1-receptor-knockdown mice. Although food intake and
energy expenditure were not significantly different between
the high fat-fed conditional Y1-receptor-knockdown and
control mice, daily energy expenditure was 5.8% higher in
the conditional Y1-knockdown mice. Interestingly, this
increase in energy expenditure and protection against diet-
induced obesity22 was not observed in germline Y1!/! mice
despite significantly increased physical activity, possibly
because of compensatory effects of germline gene deficiency.
As a minor imbalance between energy intake and expendi-
ture can lead to severe obesity over a long period of time,65
this small difference in energy expenditure may have
contributed to the reduced obesity seen in conditional Y1-
receptor-knockdown mice on the high fat diet.
Consistent with earlier studies, our data show a gender
difference in the effects of Y1-receptor deletion on adiposity,
with late-onset obesity that is more pronounced and
of earlier onset in female compared with male mice.23,25,66
Our data suggest that differential mitochondrial capacity
for substrate oxidation between male and female mice
may contribute to this gender difference in effects of Y1
signalling on adiposity. The increased overall mitochondrial
capacity for substrate oxidation seen in male versus female
mice may enhance the ability of male mice to cope with
nutrient excess. Interestingly, studies have shown that
hyperinsulinaemia is likely to be a primary aetiological
factor in the late-onset obesity of germline Y1-deficient
mice,23,25,66 being apparent in female, but not significantly
so in male Y1!/! mice before the onset of obesity. In
addition, although enhanced mitochondrial capacity for
substrate oxidation or reduced hyperinsulinaemia in male
Y1!/! mice may contribute to a delay in the onset of obesity
because of global Y1-receptor blockade, male and female
Y1!/! mice both develop obesity at an older age.23,24 Taken
together, this work highlights the importance of avoiding
hyperinsulinaemic effects of novel anti-obesity drugs based
on Y1-receptor antagonism, and the likelihood that any such
drugs may best be used in the short term or intermittently.67
As germline Y1-receptor deficiency has been associated
with enhanced function of the gonadotropic axis in
both male and female mice under conditions of energy
deficit,68,69 and as sex hormones have pronounced effects on
energy homeostatic mechanisms, it is questioned whether
Y1-receptor deletion may mediate some of its effects on
Table 4 Effects of peripheral Y1 receptor knockdown in mice on a high fat
diet
Control Conditional Y1
knockdown
Body weight (g) 32.1±0.7 28.4±0.8*
Daily food intake (g) 2.38±0.22 2.40±0.29
Daily faecal output (g) 0.46±0.06 0.45±0.12
Whole body lean mass (g) 15.98±0.28 15.56±0.25
Whole body fat mass (g) 13.76±0.81 10.60±0.93*
Whole body fat mass (% BW) 46.16±1.9 40.22±2.4
(P¼ 0.08)
Serum insulin (pM) 253.28±40.13 202.95±19.03
Rectal temperature (1C) 36.88±0.24 37.02±0.15
Physical activity (ambulatory counts per hour)
24-h 220±48 142±43
Dark phase 331±87 234±69
Light phase 110±14 51±18*
Energy expenditure (kcal per hour)
24-h 0.462±0.019 0.489±0.019
Dark phase 0.483±0.023 0.526±0.023
Light phase 0.442±0.017 0.453±0.017
Respiratory exchange ratio
24-h 0.890±0.017 0.848±0.021
Dark phase 0.893±0.018 0.860±0.031
Light phase 0.886±0.017 0.837±0.017
(P¼0.075)
Abbreviation: BW, body weight. Whole body lean and fat masses were
determined by dual energy X-ray absorptiometry. Physical activity and energy
expenditure were determined in metabolic chamber and expressed as
averages for 24-h, dark (1900–0700 h) and light (0700–1900 h) periods. For
comparison of energy expenditure by analysis of covariance, common lean
and fat mass are 15.77 and 12.18 g, respectively. Data were obtained between
15 and 21 weeks of high fat feeding and are means±s.e.m. of five mice per
group. *Po0.05 versus control mice.
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DISCUSSION 
This study shows that the regulation of oxidative fuel selection and physical activity is critically 
dependent on Y1 signalling, as germline lack of Y1 receptors resulted in a reduction in RER, 
consistent with a preference for lipid as an oxidative fuel source and a significantly increased 
physical activity with no change in energy expenditure. Importantly, these effects of germline 
Y1-receptor deletion on energy metabolism occurred in both male and female mice, but show  
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differences in the age of onset and the degree of obesity induced by germline Y1-receptor 
deletion.bib2323, bib2424 Moreover, the mechanism behind the greater utilization of lipid as an 
oxidative fuel source in mice lacking Y1 receptors most likely involves increases in hepatic and 
muscle protein levels of CPT-1 as well as increases in hepatic and muscle activity of enzymes 
involved in β-oxidation, suggesting that Y1-receptor-signalling controls mitochondrial capacity 
for fatty acid transport and oxidation. Peripherally expressed Y1 receptors have a function in 
mediating these effects, as mice with conditional knockdown of Y1 receptors, in which Y1-gene 
deletion occurs in a large variety of tissues with the highest efficiency in liver, but with no 
effect on Y1-receptor expression in the brain, led to similar changes in RER and hepatic CPT-1 
and β-oxidative enzyme activity compared with germline Y1−/− mice. Most importantly from a 
clinical perspective, peripheral Y1-receptor knockdown protected against high fat diet-induced 
increases in body weight and total adiposity in the absence of effects on lean mass or inguinal 
fat mass. As preservation of lean mass and inguinal fat during loss of excess adiposity is 
desirable because of known beneficial effects of these tissues on metabolic rate and disease 
risk,bib5454, bib5555, bib5656, bib5757, bib5858 and as these benefits could be achieved without the need 
to deliver Y1 antagonists to the brain, this finding has significant implications for the 
pharmacological management of obesity. 
 The increased fat oxidation seen in Y1-deficient mice is likely mediated by increased 
capacity for fatty acid transport into mitochondria and increased β-oxidation. Germline and 
conditional Y1-receptor-deficient mice exhibit increased protein levels of CPT-1 in skeletal 
muscle and/or liver, the two primary tissues contributing to basal metabolic rate and major 
sites of fatty acid oxidation.bib5959, bib6060, bib6161 CPT-1 is a mitochondrial transmembrane 
enzyme and considered to be rate limiting for long-chain fatty acid entry into the mitochondria 
for β-oxidation.bib6262 An increased CPT-1 expression in Y1-deficient mice suggests an 
increased capacity for fatty acid influx into mitochondria, which in itself is sufficient to increase 
fat oxidation.bib6363 This is confirmed by the significantly increased maximal activities of MCAD 
and/or β-HAD in germline and conditional Y1-receptor-knockout mice, which are key enzymes 
involved in β-oxidation.bib6464 
 In addition to increased lipid oxidation, small imbalances in energy intake versus 
expenditure may have contributed to the reduced diet-induced obesity seen conditional Y1-
receptor-knockdown mice. Although food intake and energy expenditure were not significantly 
different between the high fat-fed conditional Y1-receptor-knockdown and control mice, daily 
energy expenditure was 5.8% higher in the conditional Y1-knockdown mice. Interestingly, this 
increase in energy expenditure and protection against diet-induced obesitybib2222 was not 
observed in germline Y1−/− mice despite significantly increased physical activity, possibly 
because of compensatory effects of germline gene deficiency. As a minor imbalance between 
energy intake and expenditure can lead to severe obesity over a long period of time,bib6565 this 
small difference in energy expenditure may have contributed to the reduced obesity seen in 
conditional Y1-receptor-knockdown mice on the high fat diet. 
 Consistent with earlier studies, our data show a gender difference in the effects of Y1-
receptor deletion on adiposity, with late-onset obesity that is more pronounced and of earlier 
onset in female compared with male mice.bib2323, bib2525, bib6666 Our data suggest that differential 
mitochondrial capacity for substrate oxidation between male and female mice may contribute 
to this gender difference in effects of Y1 signalling on adiposity. The increased overall 
mitochondrial capacity for substrate oxidation seen in male versus female mice may enhance 
the ability of male mice to cope with nutrient excess. Interestingly, studies have shown that 
hyperinsulinaemia is likely to be a primary aetiological factor in the late-onset obesity of 
germline Y1-deficient mice,bib2323, bib2525, bib6666 being apparent in female, but not significantly so 
in male Y1−/− mice before the onset of obesity. In addition, although enhanced mitochondrial 
capacity for substrate oxidation or reduced hyperinsulinaemia in male Y1−/− mice may 
contribute to a delay in the onset of obesity because of global Y1-receptor blockade, male and 
female Y1−/− mice both develop obesity at an older age.bib2323, bib2424 Taken together, this work 
highlights the importance of avoiding hyperinsulinaemic effects of novel anti-obesity drugs 
based on Y1-receptor antagonism, and the likelihood that any such drugs may best be used in 
the short term or intermittently.bib6767 
 As germline Y1-receptor deficiency has been associated with enhanced function of the 
gonadotropic axis in both male and female mice under conditions of energy deficit,bib6868, bib6969 
and as sex hormones have pronounced effects on energy homeostatic mechanisms, it is 
questioned whether Y1-receptor deletion may mediate some of its effects on energy balance 
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through changes in sex hormone activity. For instance, oestrogen treatment in mice increases 
lipolysis in abdominal fat cells,bib7070 and female rodents show a dramatic increase in physical 
activity on the night of oestrous, which is abolished by removal of oestrogens (for example 
ovariectomy).bib7171 Therefore, it is possible that the increased lipid oxidation and physical 
activity evident in germline Y1−/− mice may be related to stimulation of the sex hormone axis, 
at least in females. In addition, as a decline in circulating oestrogen or androgen levels is 
associated with increased total and abdominal fat levels, which is reversed by oestrogen or 
androgen replacement,bib7272, bib7373, bib7474, bib7575 possible increases in androgen action could 
conceivably contribute to the reduced adiposity seen in young male Y1−/− mice. However, as 
Y1-receptor ablation probably influences sex hormone activity through hypothalamic 
pathways, as evidenced by up-regulation of several key factors in the hypothalamo–pituitary–
gonadal axis in Y1−/− mice,bib6868, bib6969 it is unlikely that changes in sex hormone actions 
contribute to the metabolic phenotype seen in mice with peripheral knockdown of Y1-receptor 
signalling. 
 In addition to a function of peripheral Y1 receptors in the regulation of lipid oxidation 
and accretion, this work reveals an important function of central Y1 receptors in the regulation 
of physical activity. Germline Y1−/− mice have significantly increased physical activity 
compared with wild-type controls. This is consistent with behavioural studies showing a 
hyperactive phenotype in Y1−/− mice.bib7676 Although germline Y1-receptor deficiency increases 
adiposity, particularly in female mice, and although positive energy balance itself triggers 
compensatory increases in physical activity in human beingsbib2626, bib5353 and rodents,bib5151 the 
increased physical activity of Y1−/− mice is a primary effect of Y1 deletion and not a secondary 
effect of increased adiposity, because younger female and male Y1−/− mice showed the same 
increase in physical activity in the absence of increases in fat mass. Importantly, changes in 
physical activity were not seen in our peripheral-specific Y1-receptor-knockdown mice, 
showing an important primary function of Y1 receptors in the brain in the control of physical 
activity. 
 Our conditional Y1-knockdown model showed partial deletion of the Y1 gene in various 
peripheral tissues. As the NPY-ergic system is known for its complexity and plasticity and 
compensatory changes in expression in response to germline total ablation of one of the 
system components,bib3434, bib3535, bib3636 the adult-onset general peripheral knockdown strategy 
used in this study may reduce compensatory effects of gene deletion, thus revealing the true 
function of peripheral Y1 receptors in the control of energy homeostasis. Our finding that 
peripheral Y1 receptors regulate lipid oxidation extends an earlier report that 
intracerebroventricular administration of a Y1-receptor agonist to mice increases RER, 
indicative of reduced lipid oxidation,bib1515 suggesting involvement of central Y1 receptors in 
the control of oxidative fuel selection. Although the mechanism by which this may occur is 
unclear, central Y1-mediated inhibition of sympathetic terminals innervating white adipose 
tissue could inhibit sympathetically mediated lipolysis,bib7777, bib7878 and the resultant reduction 
in fatty acid supply could also contribute to reduced lipid oxidation.bib4343 Indeed, elevated 
central NPY-ergic tone reduces sympathetic outflow,bib7979, bib8080 and central Y1 receptors have 
been implicated in these effects.bib8181, bib8282 In the periphery, one of the targets on which Y1 
receptors may exert effects on lipid metabolism are adipocytes, which express Y1 
receptorsbib2929, bib3030 and which are innervated with sympathetic neurons containing 
NPY.bib3131, bib8383 Blocking Y1-receptor signalling on isolated adipocytes from rodents and 
human beings in vitro antagonizes the anti-lipolytic effects of NPY and enhances 
lipolysis,bib8484, bib8585, bib8686, bib8787, bib3030 and this mechanism may contribute to the enhanced 
lipid oxidation seen in peripheral Y1-receptor deficiency. In addition, our findings suggest that 
Y1 receptors in the liver may have an important function in the regulation of lipid oxidation. Y1 
receptors are expressed abundantly on hepatic blood vessels,bib8888 whereas their expression 
on hepatocytes remains to be determined. NPY co-localized with norepinephrine in hepatic 
nervesbib8989 and released with norepinephrine on sympathetic nerve stimulationbib9090 may act 
on Y1 receptors expressed on hepatic blood vessels or on heptatocytes to modulate blood 
flow, and thereby indirectly or directly influence liver functions such as substrate oxidation. 
Importantly, insights from this study form the basis for future studies looking into more 
specific effects of Y1 receptors in individual tissues, such as conditional deletion of Y1 
receptors in the liver and white adipose tissue, to shed even more light onto the tissue-specific  
function of Y1 receptors in the regulation of energy metabolism. 
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 In summary, this work has revealed the critical function that peripheral Y1 
receptors have in the regulation of energy homeostasis, in particular by controlling fatty acid 
oxidation. This is of particular importance as it opens up novel therapeutic options for the 
treatment of obesity by directly targeting peripheral Y1 signalling rather than by interfering 
with central Y1-receptor-mediated control of appetite, which has proven difficult and 
ineffective. Indeed, targeting appetite-controlling systems in the brain generally only leads to 
3–5% reductions in body weight.bib9191 Targeting peripheral as opposed to central Y1 receptors 
would have the additional benefit that other important central Y1-mediated functions, such as 
control of anxiety and emotionality, would not be at risk of being affected. Thus, it will be of 
considerable interest to develop strategies to antagonize Y1 signalling in tissues that increases 
lipid oxidation without inducing hyperinsulinaemia or late-onset obesity. 
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